NCT00330044View on ClinicalTrials.gov

Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

October 31, 2009

Conditions
Inoperable Non Small Cell Lung Cancer
Interventions
DRUG

Premetrexed (Alimta)

DRUG

Carboplatin

Trial Locations (1)

19107

Thomas Jefferson University Hospital, Philadelphia

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT00330044 - Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter